The study of chemokines and chemokine receptors expression in patients with proliferative lupus nephritis
- VernacularTitle:弥漫增生型狼疮肾炎患者趋化因子及其受体的表达
- Author:
Guimei GUO
;
Shunle CHEN
;
Nan SHEN
;
Ming DAI
;
Xuming NI
;
Lin ZHENG
- Publication Type:Journal Article
- Keywords:
Lupus nephritis;
Chemotatic factors;
Receptors,ehemokine
- From:
Chinese Journal of Rheumatology
2008;12(11):731-734,插1
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the role of chemokines and ehemokine receptors in the etiopathog-enesis of diffuse proliferative lupus nephritis (LN). Methods ① Total RNA from the kidney tissues and peripheral blood cells of 12 patients with diffuse proliferative LN and 10 normal controls were prepared simultaneously and reverse transcribed into complementary DNA. Sybr green dye based real-time quantitative PCR method was used to compare the expression levels (indicated as-AACt value) of MCP-1, CCL19,CXCLg, CXCL10 and CCR2, CCR7, CXCR3. ② Immunofluoresceee labeling and immunohistochemical staining technique were used to observe the distribution of chemokines MCP-1, CCL19, CXCL9 and CXCL10 in normal and patients kidney tissues. Results The 4 chemokines genes (MCP-1, CCL19, CXCL9 and CXCL10) were consistently highly expressed in kidney tissues and peripheral blood ceils of diffuse proliferative LN patients compared with normal controls. The 2 chemokine receptors, CCR2 and CXCR3 were also overexpressed in peripheral blood cells of diffuse proliferative LN patients. There was nearly no expression of these 4 chemokine proteins in normal kidneys. But they were found in glomeruli of diffuse proliferative LN patients. Conclusion The expression of chemokines in the peripheral blood cells may be used as biomarkers for LN. Further study maybe lead to the development of specific drugs targeting at them for the treatment of systemic lupus erythematosus (SLE).
